ziftomenib
kura oncology
['leusm', 'ziftomenib']
congress | #ash22
harry erba showed that at 600mg ziftomenib, cr/crh rate was 30% in patients with npm1-mutations, and 5.6% in patients with kmt2a-rearrangments.
#leusm #medicalcongress
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm